Covered recipient · General Payments record
GABRIELLE MARIE WEYER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$2,462.09
- Reported across 34 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $903.85 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GENZYME CORPORATION | $545.04 | 6 |
| Acerta Pharma LLC | $130.46 | 2 |
| Retrophin, Inc. | $125.00 | 1 |
| CALLIDITAS THERAPEUTICS US INC. | $103.35 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $116.03 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104429989 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.43 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105611489 | CMS |
| CALLIDITAS THERAPEUTICS US INC. | $103.35 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141514669 | CMS |
| GENZYME CORPORATION | $141.81 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139743178 | CMS |
| GENZYME CORPORATION | $23.20 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139743194 | CMS |
| GENZYME CORPORATION | $122.95 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139743204 | CMS |
| GENZYME CORPORATION | $124.99 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139743242 | CMS |
| GENZYME CORPORATION | $100.17 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139743230 | CMS |
| GENZYME CORPORATION | $31.92 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139743270 | CMS |
| Travere Therapeutics, Inc. | $125.00 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149961170 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.